User Tools

    To create and edit articles, please register and log-in

Main Menu : categories & index etc.

Main menu
Click categories to expand

A-Z listingplugin-autotooltip__plain plugin-autotooltip_bigA-Z listing

This is an alphabetical index of all content pages.

Other categories



Also see

Importance Ratings
Curator's rationale
AI Policy

Twitter feed š¯•¸

Feeds + s.e.o. etc.
rss / xml feed
sitemap file
A-Z listing (archived)

Indexed under : Medicine / Drugs

Wikenigma - an Encyclopedia of Unknowns Wikenigma - an Encyclopedia of the Unknown


Minoxidil (currently sold under the brand names of Rogaine, Loniten, Lonolox, Noxidil, Pilomin, Reten and more than 100 others) is a widely used medication for the treatment of hair loss.

It was originally developed (1950s) as an oral medication for stomach ulcers - for which it proved ineffective. During trials, it was discovered that the drug had a strong effect in lowering blood pressure, and was later approved as a treatment forhypertensionplugin-autotooltip__plain plugin-autotooltip_bigHypertension

Only 5 -10% of cases of hypertension (high blood pressure) have causes which can be clearly identified - e.g. due to narrowing of the arteries. Put another way, of those patients who have been identified as having abnormally high blood pressure, physicianā€¦
. (Because of its wide range of unpleasant side effects, it was normally only used when other medications had failed.)

During its use it was found to induce hypertrichosis (excessive hair growth) in many patients. It was subsequently adopted as as a hair growth stimulant in the form of external ointments. Which is now its main medical use.

In this respect, its mechanism of action is currently unknown.

The mechanism by which minoxidil, an adenosine-triphosphate-sensitive potassium channel opener, induces hypertrichosis remains to be elucidated. Minoxidil has been reported to stimulate the production of vascular endothelial growth factor, a possible promoter of hair growth, in cultured dermal papilla cells. The mechanism of production of vascular endothelial growth factor remains unclear, however.

Source :Journal of Investigative Dermatology Volume 117, Issue 6,

    Please share this page to help promote Wikenigma !

Dear reader : Do you have any suggestions for the site's content?

Ideas for new topics, and suggested additions / corrections for older ones, are always welcome.

If you have skills or interests in a particular field, and have suggestions for Wikenigma, get in touch !

Or, if you'd like to become a regular contributor . . . request a login password. Registered users can edit the entire content of the site, and also create new pages.

( The 'Notes for contributors' section in the main menu has further information and guidelines etc.)

Automatic Translation

You are currently viewing an auto-translated version of Wikenigma

Please be aware that no automatic translation engines are 100% accurate, and so the auto-translated content will very probably feature errors and omissions.

Nevertheless, Wikenigma hopes that the translated content will help to attract a wider global audience.

Show another (random) article

Further resources :